Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)

OBJECTIVE: To investigate the functional and quality of life (QoL) outcomes of treatments for localised prostate cancer and inform treatment decision‐making. PATIENTS AND METHODS: Men aged 50–69 years diagnosed with localised prostate cancer by prostate‐specific antigen testing and biopsies at nine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lane, Janet Athene, Donovan, Jenny L., Young, Grace J., Davis, Michael, Walsh, Eleanor I., Avery, Kerry N.L., Blazeby, Jane M., Mason, Malcolm D., Martin, Richard M., Peters, Tim J., Turner, Emma L., Wade, Julia, Bollina, Prasad, Catto, James W.F., Doherty, Alan, Gillatt, David, Gnanapragasam, Vincent, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Oxley, Jon, Paul, Alan, Paez, Edgar, Rosario, Derek J., Rowe, Edward, Staffurth, John, Neal, David E., Hamdy, Freddie C., Metcalfe, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543725/
https://www.ncbi.nlm.nih.gov/pubmed/35373443
http://dx.doi.org/10.1111/bju.15739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543725/
https://www.ncbi.nlm.nih.gov/pubmed/35373443
http://dx.doi.org/10.1111/bju.15739

Ejemplares similares